Author

J. G. Julander

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Organism:human· 1 Organism:non-human primate· 1

Frequent Co-Authors

A. Bailey· 1 shared A. Moussa· 1 shared A. Weight· 1 shared A. Yrizarry-Medina· 1 shared B. C. Rosen· 1 shared B. J. Burwitz· 1 shared C. A. Nelson· 1 shared C. Gainza· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Bailey

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Therapeutic neutralizing monoclonal antibody administration protects against lethal viscerotropic Yellow Fever infection

M. J. Ricciardi, L. N. Rust, N. Pedreno-Lopez, S. Yusova, S. Biswas, G. M. Webb, M. Fischer, L. Gonsales-Nieto, T. B. Voigt, J. J. Louw, F. D. Laurino, J. R. DiBello, H.-P. Raue, L. M. S. Raphael, A. Yrizarry-Medina, , B. J. Burwitz

Therapeutic monoclonal antibodies prevent death from YFV infection.

bioRxiv · May 16, 2022 · PreprintImmunology

Isolation of a potently neutralizing and protective human monoclonal antibody targeting yellow fever virus

J. E. Crowe, M. Doyle, J. R. Genualdi, A. Bailey, N. Kose, C. Gainza, J. Rodriguez, K. M. Reeder, C. A. Nelson, P. N. Jethva, R. E. Sutton, R. G. Bombardi, M. Gross, J. G. Julander, D. H. Fremont, M. Diamond

The paper isolates a human monoclonal antibody that neutralizes yellow fever virus and provides therapeutic protection in animal models.

bioRxiv · Feb 28, 2022Immunology

AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model

K. Lin, S. S. Good, J. G. Julander, A. Weight, A. Moussa

This paper demonstrates that AT-752, a prodrug of a guanosine nucleotide analog, reduces YFV viremia and liver damage in hamsters and improves survival rates.

bioRxiv · Oct 25, 2021Pharmacology & Toxicology